[1]
“Real-World Pharmacovigilance Analysis of Suicidal Ideation and Self-Injurious Behavior Associated with GLP-1 Receptor Agonists: Disproportionality and Mechanistic Insights”, Pjmcr, vol. 5, no. 1, pp. 5819–5836, Mar. 2026, doi: 10.5281/zenodo.23010673.